Novo Nordisk A just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Novo Nordisk A claims to own 123,323 shares. This represents 0.2% of Affimed Therapeutics.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Affimed Therapeutics makes a similar move, sign up!
Other recent filings from the company include the following:
Brookside Capital just provided an update on share ownership of Affimed Therapeutics - Feb. 14, 2019
Wellington Management Company LLP just provided an update on share ownership of Affimed Therapeutics - Feb. 12, 2019